Lyell Immunopharma Filing Becomes Effective
Ticker: LYEL · Form: EFFECT · Filed: Apr 15, 2026 · CIK: 0001806952
| Field | Detail |
|---|---|
| Company | Lyell Immunopharma, Inc. (LYEL) |
| Form Type | EFFECT |
| Filed Date | Apr 15, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, effectiveness, securities
TL;DR
Lyell Immunopharma's filing is officially effective as of 4/14/2026.
AI Summary
Lyell Immunopharma, Inc. filed an EFFECT form on April 15, 2026, indicating the effectiveness of a filing related to their securities. The filing, with accession number 9999999995-26-001185, was accepted at 00:15:12. The effectiveness date is listed as April 14, 2026.
Why It Matters
This filing signifies a key regulatory step for Lyell Immunopharma, potentially related to a securities offering or registration, which could impact its financial structure and future operations.
Risk Assessment
Risk Level: low — This is a procedural filing indicating effectiveness, not a direct financial event like an offering or acquisition.
Key Numbers
- 2026-04-14 — Effectiveness Date (The date the filing officially became active.)
- 2026-04-15 — Acceptance Date (The date the SEC accepted the filing.)
Key Players & Entities
- Lyell Immunopharma, Inc. (company) — Filer
- 9999999995-26-001185 (dollar_amount) — SEC Accession Number
- 2026-04-15 (dollar_amount) — Acceptance Date
- 2026-04-14 (dollar_amount) — Effectiveness Date
FAQ
What type of filing is an 'EFFECT' form?
An 'EFFECT' form in SEC filings typically indicates that a registration statement or other filing has become effective, meaning it has met the necessary regulatory requirements and can proceed.
What is the accession number for this filing?
The accession number for this filing is 9999999995-26-001185.
When did this filing become effective?
The filing became effective on April 14, 2026.
When was this filing accepted by the SEC?
This filing was accepted by the SEC on April 15, 2026, at 00:15:12.
What is Lyell Immunopharma, Inc.'s CIK number?
Lyell Immunopharma, Inc.'s CIK number is 0001806952.
Filing Details
This Form EFFECT (Form EFFECT) was filed with the SEC on April 15, 2026 regarding Lyell Immunopharma, Inc. (LYEL).